Ifenprodil
Idiopathic Pulmonary Fibrosis · ANZCTR
Clinical trials
1
Mechanism
ANZCTR
Developer
Algernon Pharmaceuticals
Overview
Ifenprodil is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via anzctr. It appears in 1 tracked IPF clinical trial.
Ifenprodil clinical trials
Explore related
Medical disclaimer. This page summarizes research about Ifenprodil for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.